5 completed, 2 unknown, 1 terminated. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 5, Unknown 2, Terminated 1 |
Follow nitazoxanide: new trials by email Literature Review of nitazoxanide trials Research Report on nitazoxanide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Study of Secondary Prophylaxis for SBP Norfloxacin 400 MG, Nitazoxanide 500 MG, Colistin - Spontaneous Bacterial Peritonitis, Cirrhoses, Liver | Phase 4 | Completed | Tanta University | 90 | 2021-03-01 | 2025-02-14 |
| Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19 in Household Contacts Nitazoxanide, Placebo - Covid19, SARS-CoV-2 Infection | Phase 4 | Unknown | Fundación Huésped | 456 | 2020-12-01 | 2021-07-02 |
| Sofosbuvir/Ledipasvir and Nitazoxanide for Treatment of COVID-19 Sofosbuvir and Ledipasvir, Nitazoxanide - COVID | Phase 4 | Completed | Assiut University | 240 | 2020-07-15 | 2020-11-12 |
| Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide Nitazoxanide 500Mg Oral Tablet - Coronavirus Infection | Phase 4 | Completed | Materno-Perinatal Hospital of the State of Mexico | 150 | 2020-05-21 | 2021-03-30 |
| Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19 Nitazoxanide 500 MG, Hydroxychloroquine - Coronavirus Infection | Phase 4 | Terminated | Hugo Mendieta Zeron | 44 | 2020-04-06 | 2021-04-01 |
| Trial Comparing the Efficacy, Tolerability and Safety Between Three Arms in Treatment of HCV in Egyptian Population Reiferon Retard in Arm 1, Bon one in Arm 3, Xerovirinc in Arm 2 - Chronic Hepatitis c | Phase 4 | Unknown | MinaPharm Pharmaceuticals | 300 | 2013-06-01 | 2013-07-11 |
| The Role Of Nitazoxanide, Interferon Alfa And Ribavirin In Treatment Of Hepatitis C Infected Type 2 Diabetic Patients nitazoxanide, conventional interferon alfa, Ribavirin - Hepatitis C, Chronic, DIABETES MELLITUS Type 2 | Phase 4 | Completed | Services Institute of Medical Sciences, Pakistan | 66 | 2011-07-01 | 2013-09-20 |
| Irritable Bowel Syndrome Evaluation and Treatment in Primary Care Bifidobacterium infantis, Pancrelipase, Nitazoxanide - Irritable Bowel Syndrome | Phase 4 | Completed | American Academy of Family Physicians | 61 | 2010-11-01 | 2019-01-23 |
Coronavirus Infections (2) · Hepatitis C, Chronic (2) · Ascites (1) · COVID-19 (1) · Diabetes Mellitus, Type 2 (1) · Exocrine Pancreatic Insufficiency (1) · Irritable Bowel Syndrome (1)
American Academy of Family Physicians (1) · Assiut University (1) · Fundación Huésped (1) · Hugo Mendieta Zeron (1) · Materno-Perinatal Hospital of the State of Mexico (1) · MinaPharm Pharmaceuticals (1) · Services Institute of Medical Sciences, Pakistan (1) · Tanta University (1)
Egypt (3) · Mexico (2) · Argentina (1) · Pakistan (1) · United States (1)
Gamal Esmat, MD (1) · Gerard Mullin, MD (1) · Haidi K Ramadan, PhD (1) · Herman K Ludvik, MD (1) · Madiha Fida, MBBS (1) · Mohamed El Kassas, PhD (1) · Mohammed A Medhat, PhD (1) · Omar Sued, MD PhMD (1) · Rasha Ahmed, MD (1) · Srivatsan Padmanabhan, MD, PhD (1)